By João Luis D’Orey Facco Vianna

August 9, 2017

Published ANVISA’s new rule relative to the prior consent for the granting of a patent for pharmaceutical products and processes

Valid since August 10 2017 – date of its publication on the Official Federal Gazette – this new rule confirms all the principals and procedures already stated on Normative Instruction Nº 01, from May 31 2017.

In case you need further information on this topic, our legal and technical teams are at your disposal in our offices of Rio de Janeiro, São Paulo and Porto Alegre, as well as the email: mail@kasznarleonardos.com

Back

Last by João Luis D’Orey Facco Vianna

September 25, 2023

Interview: João Vianna for Managing IP

Our partner João Vianna was interviewed by Managing IP, a website specializing in Intellectual Property analysis. The article featuring Vianna discusses the … Interview: João Vianna for Managing IP

João Luis D’Orey Facco Vianna

April 15, 2020

The Brazilian PTO establishes prioritization of technologies associated with the treatment and diagnosis of Covid-19

By means of publication made in the Official Gazette 2,570, dated April 7th, 2020, the Brazilian Patent Office promulgated Ordinance No. 149/2020, … The Brazilian PTO establishes prioritization of technologies associated with the treatment and diagnosis of Covid-19

October 25, 2019

BPTO publishes new rules to request participation on Patent Prosecution Highway (PPH) programs

The Brazilian Patent and Trademark Office (BPTO) published Resolution 225/19 which institutes rulings on the pilot project for the Patent Prosecution Highway … BPTO publishes new rules to request participation on Patent Prosecution Highway (PPH) programs